Correction of the Δ508-CFTR processing defect by a structural analogue of sildenafil

被引：0
|
作者：
Robert, R. [1 ]
Carlile, G. W. [1 ]
Pavel, C. [1 ]
Liao, J. [1 ]
Thomas, D. Y. [1 ]
Hanrahan, J. W. [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
PEDIATRIC PULMONOLOGY | 2007年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
69
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [1] Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect
    Robert, Renaud
    Carlile, Graeme W.
    Pavel, Catalin
    Liu, Na
    Anjos, Suzana M.
    Liao, Jie
    Luo, Yishan
    Zhang, Donglei
    Thomas, David Y.
    Hanrahan, John W.
    MOLECULAR PHARMACOLOGY, 2008, 73 (02) : 478 - 489
  • [2] Correction of ΔF508-CFTR trafficking defect by deoxyspergualin.
    Jiang, C
    Xiao, Y
    Fang, S
    Nadler, SG
    Lee, D
    Jefferson, D
    Kaplan, J
    Smith, AE
    Cheng, SH
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A679 - A679
  • [3] Evaluation of correctors on the rescue of Δ508-CFTR chloride channel activity in FRT-cells
    Bridges, R.
    Nagubadi, S.
    Thakerar, A.
    Jia, Y.
    Bradbury, N. A.
    PEDIATRIC PULMONOLOGY, 2007, : 225 - 225
  • [4] Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
    Van Goor, Fredrick
    Hadida, Sabine
    Grootenhuis, Peter D. J.
    Burton, Bill
    Stack, Jeffrey H.
    Straley, Kimberly S.
    Decker, Caroline J.
    Miller, Mark
    McCartney, Jason
    Olson, Eric R.
    Wine, Jeffrey J.
    Frizzell, Ray A.
    Ashlock, Melissa
    Negulescu, Paul A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (46) : 18843 - 18848
  • [5] STRUCTURAL DEFECT TARGETED SCREENING ASSAYS LEAD TO THE PHARMACOLOGICAL DISSECTION OF CFTR MISFOLDING AND IMPROVED F508DEL CORRECTION
    Liang, F.
    Shang, H.
    Jordan, N. J.
    Wong, E.
    Veit, G.
    Lukacs, G. L.
    Bihler, H. J.
    Mense, M.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 217 - 217
  • [6] Processing correction and direct activation of ΔF508 CFTR by the flavonoid equol in vitro
    Rowe, S. M.
    Varga, K.
    Bebok, Z.
    Li, Y.
    Fan, L.
    Nowartowski, K.
    Prasin, J.
    Barnes, S.
    Clancy, J. P.
    Sorscher, E. J.
    PEDIATRIC PULMONOLOGY, 2007, : 299 - 299
  • [7] Correcting the trafficking defect of ΔF508 CFTR
    Thomas, D.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2010, 88 (02): : 409 - 409
  • [8] Correction of ΔF508 CFTR trafficking defect by a novel family of marine sponge derived alkaloids
    Carlile, G. W.
    Keyzers, R. A.
    Teske, K. A.
    Robert, R.
    Williams, D. E.
    Linington, R.
    Gray, C. A.
    Hanrahan, J.
    Andersen, R. J.
    Thomas, D. Y.
    PEDIATRIC PULMONOLOGY, 2007, : 287 - 287
  • [9] Mild processing defect of porcine ΔF508-CFTR suggests that ΔF508 pigs may not develop cystic fibrosis disease
    Liu, Yanli
    Wang, Ying
    Jiang, Yong
    Zhu, Na
    Liang, Haitao
    Xu, Lina
    Feng, Xuechao
    Yang, Hong
    Ma, Tonghui
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 373 (01) : 113 - 118
  • [10] Role for phospholipid interactions in the trafficking defect of ΔF508-CFTR
    Eidelman, O
    BarNoy, S
    Razin, M
    Zhang, J
    McPhie, P
    Lee, G
    Huang, Z
    Sorscher, EJ
    Pollard, HB
    BIOCHEMISTRY, 2002, 41 (37) : 11161 - 11170
12345